Skip to main content
. 2015 Oct 6;6(35):38360–38371. doi: 10.18632/oncotarget.5256

Table 2. Patient-specific chromosomal rearrangements used for ctDNA monitoring.

Patient SV Chromosomal Positionsa GenomicRegionb Genesc
ChrA Position ChrB Position
1 T01 17 35126102 1 223988874 - intragenic TP53BP2
1 T02 8 40477264 2 152374971 - intragenic ZMAT4, NEB
2 D01 3 60342822 3 60388671 ∼45 Kb intragenic FHIT
2 D02 4 185436839 4 185913887 ∼500 Kb intergenic
3 T01 8 93421404 6 13191227 - intragenic PHACTR1
3 T02 12 3607669 6 145470434 - intragenic PRMT8
4 I01 12 1819278 12 −1870423 ∼50 Kb intragenic ADIPOR2
4 D02 17 39823076 17 39837384 ∼14 Kb intragenic JUP

Abbreviations: (SV) Structural Variation; (D) Deletion; (I) Inversion; (T) Translocation; (ChrA) Chromosome A; (ChrB) Chromosome B.

a

Chromosomal positions were based on human genome reference sequence (hg19), negative signal indicates sequences aligning to the minus strand.

b

Genomic Region: approximate size (Kb) of genomic regions involved in deletions and inversions; genomic context base on gene annotation.

c

Genes: genes involved in patient-specific chromosomal rearrangements.